COP vs PACB · P/E 19, rev $58.94B vs rev $38.4M
ConocoPhillips (COP) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
COP currently screens at market cap $135.49B and trailing P/E 18.8. PACB currently screens at market cap $387.1M.
Not investment advice. Open the COP and PACB stock pages for the full models.
Not investment advice.